Endoscopic Strip Craniectomy for Craniosynostosis
Trial Summary
What is the purpose of this trial?
* Endoscopic strip craniectomy (ESC) with post-operative helmeting is the gold-standard treatment for isolated, non-syndromic sagittal craniosynostosis in children under 6 months of age as it is has been demonstrated to reduce perioperative morbidity when compared to more invasive procedures such as cranial vault remodeling. ESC is frequently performed with or without the use of lateral osteotomies with technical selection being largely based on surgeon preference. * Previous studies have shown that there are no statistically significant differences in cranial expansion or complications between the two procedure variants; however, these studies are retrospective in nature and do not account for aesthetic outcomes. * The purpose of this study is to compare the efficacy of ESC with or without the use of lateral osteotomies in regard to cranial expansion and aesthetic outcomes for children treated with isolated, non-syndromic sagittal craniosynostosis. In addition, we seek to investigate if there are any observable changes in perioperative morbidity between the two procedures.
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications.
Is endoscopic strip craniectomy generally safe for humans?
How is endoscopic strip craniectomy with helmet therapy different from other treatments for craniosynostosis?
Endoscopic strip craniectomy with helmet therapy is a minimally invasive treatment for craniosynostosis that uses small incisions and an endoscope (a thin tube with a camera) to remove the fused skull suture, followed by helmet therapy to shape the skull as it heals. This approach is less invasive than traditional open surgery, potentially reducing recovery time and complications, and it can be performed with a single incision, offering cosmetic benefits and minimizing wound issues.13467
Research Team
David F Bauer, MD, MPH
Principal Investigator
Baylor College of Medicine
Eligibility Criteria
This trial is for babies under 6 months old with a condition called isolated, non-syndromic sagittal craniosynostosis. They must be patients at Texas Children's Hospital and able to have the surgery before reaching 6 months of age.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo endoscopic strip craniectomy with or without lateral osteotomies, followed by post-operative helmeting
Post-operative Monitoring
Standard post-operative visits and measurements of cephalic index using the STARscanner©, along with chart reviews
Follow-up
Participants are monitored for cranial expansion and aesthetic outcomes at 1 year post-operatively
Treatment Details
Interventions
- Endoscopic strip craniectomy (with lateral osteotomies) with post-operative helmet therapy
- Endoscopic strip craniectomy (without lateral osteotomies) with post-operative helmet therapy
- Endoscopic strip craniectomy with post-operative helmet therapy
Endoscopic strip craniectomy (with lateral osteotomies) with post-operative helmet therapy is already approved in European Union, United States, Canada for the following indications:
- Isolated, non-syndromic sagittal craniosynostosis in children under 6 months of age
- Isolated, non-syndromic sagittal craniosynostosis in children under 6 months of age
- Syndromic craniosynostosis in selected cases
- Isolated, non-syndromic sagittal craniosynostosis in children under 6 months of age
Find a Clinic Near You
Who Is Running the Clinical Trial?
Baylor College of Medicine
Lead Sponsor